Flow Health provides ordering clinicians with unmatched information and insights to understand how a patient’s laboratory reports may guide a patient’s diagnostic or treatment plan.
We do this by measuring evidence-based risk stratifications (e.g., ASCVD, Framingham), displaying calculated markers (e.g., Anion Gap, HOMA-IR) and offering proprietary multi-biomarker in-silco laboratory developed tests.
Advancing science and medicine
Flow Health is committed to improving patient outcomes by advancing the understanding of disease and how to best treat them, while providing insights to inform clinicians and patients in their care decisions.
Dementia is not a normal part of aging. Our objective is to identify predictors of dementia and other cognitive impairments.
Inflammation is a common underlying factor in obesity, insulin resistance, hypertension, and cardiovascular disease. We aim to discover knowledge on dietary causes of inflammation and their effects on disease.